Refined By:
Author:  Mooranian A.
Date Issued:  2014

Results 1-4 of 4 (Search time: 0.001 seconds).

Issue DateTitleAuthor(s)
19-Sep-2014Microencapsulation as a novel delivery method for the potential antidiabetic drug, ProbucolMooranian A.; Negrulj R.; Chen-Tan N.; Al-Sallami H.; Fang Z.; Mukkur T.; Momir Mikov ; Svetlana Goločorbin-Kon ; Fakhoury M.; Watts G.; Matthews V.; Arfuso F.; Al-Salami H.
228-Jul-2014Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A characterization studyMooranian A.; Negrulj R.; Chen-Tan N.; Al-Sallami H.; Fang Z.; Mukkur T.; Momir Mikov ; Svetlana Goločorbin-Kon ; Fakhoury M.; Arfuso F.; Al-Salami H.
31-Jan-2014Probucol Release from Novel Multicompartmental Microcapsules for the Oral Targeted Delivery in Type 2 DiabetesMooranian A.; Negrulj R.; Al-Sallami H.; Fang Z.; Momir Mikov ; Svetlana Goločorbin-Kon ; Fakhoury M.; Watts G.; Matthews V.; Arfuso F.; Lambros A.; Al-Salami H.
41-Jan-2014Stability and release kinetics of an advanced gliclazide-cholic acid formulation: The Use of artificial-cell microencapsulation in slow release targeted oral delivery of antidiabeticsMooranian A.; Negrulj R.; Mathavan S.; Martinez J.; Sciarretta J.; Chen-Tan N.; Mukkur T.; Momir Mikov ; Mladena Lalić-Popović ; Maja Stojancěvić; Svetlana Goločorbin-Kon ; Al-Salami H.